CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1− Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B CellsLei Tao, Wenzheng Jiang, Congyi Niu et al.|Cancers|2020Cited by 36
CAR T Cells Engineered to Secrete IFNκ Induce Tumor Ferroptosis via an IFNAR/STAT1/ACSL4 AxisYaoxin Gao, Yi Zhang|Cancer Immunology Research|2024Cited by 22